Review



anti ubiquitin k48 linkage specific antibody  (Boster Bio)


Bioz Verified Symbol Boster Bio is a verified supplier
Bioz Manufacturer Symbol Boster Bio manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 91

    Structured Review

    Boster Bio anti ubiquitin k48 linkage specific antibody
    Summary of Pharmacodynamic (PD) modulation data from dogs receiving Powder in Capsule (PIC) or Human Clinical Formulation (HCF) of CB-5339
    Anti Ubiquitin K48 Linkage Specific Antibody, supplied by Boster Bio, used in various techniques. Bioz Stars score: 91/100, based on 2 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti ubiquitin k48 linkage specific antibody/product/Boster Bio
    Average 91 stars, based on 2 article reviews
    anti ubiquitin k48 linkage specific antibody - by Bioz Stars, 2026-03
    91/100 stars

    Images

    1) Product Images from "Comparative oncology assessment of a novel inhibitor of valosin-containing protein in tumor-bearing dogs"

    Article Title: Comparative oncology assessment of a novel inhibitor of valosin-containing protein in tumor-bearing dogs

    Journal: Molecular cancer therapeutics

    doi: 10.1158/1535-7163.MCT-22-0167

    Summary of Pharmacodynamic (PD) modulation data from dogs receiving Powder in Capsule (PIC) or Human Clinical Formulation (HCF) of CB-5339
    Figure Legend Snippet: Summary of Pharmacodynamic (PD) modulation data from dogs receiving Powder in Capsule (PIC) or Human Clinical Formulation (HCF) of CB-5339

    Techniques Used: Formulation, Clinical Proteomics

    Comparison of timecourse samples representative of induction of pharmacodynamic markers K48 linkage-specific ubiquitin (A) and CHOP (B, by mRNA) in serial biopsy samples taken from 6 dogs receiving the human clinical formulation of CB-5339.
    Figure Legend Snippet: Comparison of timecourse samples representative of induction of pharmacodynamic markers K48 linkage-specific ubiquitin (A) and CHOP (B, by mRNA) in serial biopsy samples taken from 6 dogs receiving the human clinical formulation of CB-5339.

    Techniques Used: Comparison, Ubiquitin Proteomics, Formulation



    Similar Products

    Image Search Results